Amid the dozens of publicly traded firms in Minnesota, Baudette-based ANI Pharmaceuticals Inc. often flies under the radar. The pharmaceutical company about five hours north of Minneapolis has grown ...
Shares of specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) jumped 13.6% in the afternoon session after the company provided strong 2026 financial guidance that surpassed analyst ...
ANI is growing its capabilities and pipeline with an acquisition. The company has signed a definitive agreement to acquire Novitium Pharma for $163.5 million, including $89.5 million in cash and $74 ...
ANI Pharmaceuticals is up 2.8% since the beginning of the year, but at $80.59 per share, it is still trading 18.4% below its 52-week high of $98.81 from September 2025. Investors who bought $1,000 ...
Indian news agency ANI has filed a lawsuit against OpenAI, alleging copyright infringement. ANI claims OpenAI used its content without permission to train its AI chatbot, ChatGPT, and even attributed ...
-- Combined company creates generics growth engine with technical capabilities to bring complex, high-value products to market in efficient and cost effect manner -- -- Proven track record with ...
BAUDETTE, Minn.--(BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that it has signed a definitive agreement to acquire Novitium Pharma, a privately ...
ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, and contract manufacturing. Despite cash burn concerns, ANI's revenue ...
In May 2025, YouTuber Mohak Mangal opened a can of worms when he put out a video claiming to be ‘extorted’ by news agency Asian News International (ANI). In the 11-minute video, Mangal spoke about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results